Vaishali Pharma Limited

VAISHALI NSE Healthcare Pharmaceuticals
₹8.77
+2.33%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.28.
  • Promoters hold a sizeable stake (30.54%).

!Watch-points

  • Return on equity is on the lower side at 6%.
  • Net profit margin is slim at 3.7%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.04

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the working-capital term (current-asset split not available for this stock).

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 114 Cr
Current Price₹ 8.77
High / Low₹ 12.70 / 4.75
Stock P/E25.60
Book Value₹ 5.30
Dividend Yield0%
ROCE
ROE6.02%
Face Value₹ 2.00
Debt to Equity0.28
PEG Ratio
EV / EBITDA26.60
Industry PE35.70
P/B Ratio1.6553417
EPS₹ 0.32
Debt₹ 19 Cr
PAT Margin3.67%
Cash PAT₹ 5 Cr
ICR2.00
Promoter Holding30.54%
FII Holding
DII Holding
Public Holding69.46%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years 18.00%
3 Years -11.00%
1 Year -27.00%
Return on Equity
10 Years
5 Years
3 Years
Last Year 6.00%
Educational data only. Not a recommendation to buy, sell or hold any security.